Progress in the treatment of acute promyelocytic leukemia: optimization and obstruction

被引：18

作者：

Li, Junmin ^{[1
]}

Zhu, Hongming ^{[1
]}

Hu, Jiong ^{[1
]}

Mi, Jianqing ^{[1
]}

Chen, Saijuan ^{[1
]}

Chen, Zhu ^{[1
]}

Wang, Zhenyi ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hematol, Rui Jin Hosp, Shanghai 200030, Peoples R China

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2014年 / 100卷 / 01期

关键词：

Acute promyelocytic leukemia; All-trans retinoic acid; Arsenic trioxide; Optimization therapy; TRANS-RETINOIC ACID; AGENT ARSENIC TRIOXIDE; RISK-ADAPTED TREATMENT; EARLY DEATH RATE; TERM-FOLLOW-UP; SINGLE-AGENT; ANTHRACYCLINE MONOCHEMOTHERAPY; CONSOLIDATION THERAPY; GEMTUZUMAB-OZOGAMICIN; CELL TRANSPLANTATION;

D O I：

10.1007/s12185-014-1603-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The past three decades have witnessed a great progress in the treatment of acute promyelocytic leukemia (APL). The current application of all-trans retinoic acid, arsenic trioxide (ATO), and anthracycline-based chemotherapies has been proved to be highly effective. Based on the risk factors of APL, optimization of the treatment emphasizes the role of ATO in induction, consolidation and maintenance therapy as a substitute to chemotherapy in low-and intermediate-risk patients, and in potential reduction of chemotherapy in high-risk group without impact on the outcome. However, early death and relapse remain obstacles to further improvement of the rates of remission and long-term survival, and the acute and chronic adverse effects of ATO should be considered for more appropriate management. Efforts should be made to more rationally obtain improved outcomes through the use of less toxic regimens.

引用

页码：38 / 50

页数：13

共 81 条

[1] Treatment of newly diagnosed acute promyelocytic leukemia (APL):: a comparison of French-Belgian-Swiss and PETHEMA results [J].

Ades, Lionel ;

Sanz, Miguel A. ;

Chevret, Sylvie ;

Montesinos, Pau ;

Chevallier, Patrice ;

Raffoux, Emmanuel ;

Vellenga, Edo ;

Guerci, Agnbs ;

Pigneux, Arnaud ;

Huguet, Francoise ;

Rayon, Consuelo ;

Stoppa, Anne Marie ;

de la Serna, Javier ;

Cahn, Jean-Yves ;

Meyer-Monard, Sandrine ;

Pabst, Thomas ;

Thomas, Xavier ;

de Botton, Stephane ;

Parody, Ricardo ;

Bergua, Juan ;

Lamy, Thierry ;

Vekhoff, Anne ;

Negri, Silvia ;

Ifrah, Norbert ;

Dombret, Herve ;

Ferrant, Augustin ;

Bron, Dominique ;

Degos, Laurent ;

Fenaux, Pierre .

BLOOD, 2008, 111 (03) :1078-1084

[2] Is cytarabine useful in the treatment of acute promyelocytic leukemia?: Results of a randomized trial from the European Acute Promyelocytic Leukemia Group [J].

AdeS, Lionel ;

Chevret, Sylvie ;

Raffoux, Emmanuel ;

de Botton, Stephane ;

Guerci, Agnes ;

Pigneux, Arnaud ;

Stoppa, Anne Marie ;

Lamy, Thierry ;

Rigal-Huguet, Francoise ;

Vekhoff, Anne ;

Meyer-Monard, Sandrine ;

Maloisel, Frederic ;

Deconinck, Eric ;

Ferrant, Augustin ;

Thomas, Xavier ;

Fegueux, Nathalie ;

Chomienne, Christine ;

Dombret, Herve ;

Degos, Laurent ;

Fenaux, Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) :5703-5710

[3] Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients [J].

Ades, Lionel ;

Chevret, Sylvie ;

Raffoux, Emmanuel ;

Guerci-Bresler, Agnes ;

Pigneux, Arnaud ;

Vey, Nobert ;

Lamy, Thierry ;

Huguet, Francoise ;

Vekhoff, Anne ;

Lambert, Jean-Francois ;

Lioure, Bruno ;

de Botton, Stephane ;

Deconinck, Erick ;

Ferrant, Augustin ;

Thomas, Xavier ;

Quesnel, Bruno ;

Cassinat, Bruno ;

Chomienne, Christine ;

Dombret, Herve ;

Degos, Laurent ;

Fenaux, Pierre .

AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) :556-559

[4] Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience [J].

Ades, Lionel ;

Guerci, Agnes ;

Raffoux, Emmanuel ;

Sanz, Miguel ;

Chevallier, Patrice ;

Lapusan, Simona ;

Recher, Christian ;

Thomas, Xavier ;

Rayon, Consuelo ;

Castaigne, Sylvie ;

Tournilhac, Olivier ;

de Botton, Stephane ;

Ifrah, Norbert ;

Cahn, Jean-Yves ;

Solary, Eric ;

Gardin, Claude ;

Fegeux, Nathalie ;

Bordessoule, Dominique ;

Ferrant, Augustin ;

Meyer-Monard, Sandrine ;

Vey, Norbert ;

Dombret, Herve ;

Degos, Laurent ;

Chevret, Sylvie ;

Fenaux, Pierre .

BLOOD, 2010, 115 (09) :1690-1696

[5]

Alimoghaddam K, 2011, ARCH IRAN MED, V14, P167, DOI 011143/AIM.004

[6] A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy:: The Japan Adult Leukemia Study Group (JALSG) APL97 study [J].

Asou, Norio ;

Kishimoto, Yuji ;

Kiyoi, Hitoshi ;

Okada, Masaya ;

Kawai, Yasukazu ;

Tsuzuki, Motohiro ;

Horikawa, Kentaro ;

Matsuda, Mitsuhiro ;

Shinagawa, Katsuji ;

Kobayashi, Tohru ;

Ohtake, Shigeki ;

Nishimura, Miki ;

Takahashi, Masatomo ;

Yagasaki, Fumiharu ;

Takeshita, Akihiro ;

Kimura, Yukihiko ;

Lwanaga, Masako ;

Naoe, Tomoki ;

Ohno, Ryuzo .

BLOOD, 2007, 110 (01) :59-66

[7] Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study [J].

Au, Wing-Yan ;

Kumana, Cyrus R. ;

Lee, Harold K. K. ;

Lin, Shek-Ying ;

Liu, Herman ;

Yeung, Dominic Y. M. ;

Lau, June S. M. ;

Kwong, Yok-Lam .

BLOOD, 2011, 118 (25) :6535-6543

[8] AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance [J].

Avvisati, Giuseppe ;

Lo-Coco, Francesco ;

Paoloni, Francesca Paola ;

Petti, Maria Concetta ;

Diverio, Daniela ;

Vignetti, Marco ;

Latagliata, Roberto ;

Specchia, Giorgina ;

Baccarani, Michele ;

Di Bona, Eros ;

Fioritoni, Giuseppe ;

Marmont, Filippo ;

Rambaldi, Alessandro ;

Di Raimondo, Francesco ;

Kropp, Maria Grazia ;

Pizzolo, Giovanni ;

Pogliani, Enrico M. ;

Rossi, Giuseppe ;

Cantore, Nicola ;

Nobile, Francesco ;

Gabbas, Attilio ;

Ferrara, Felicetto ;

Fazi, Paola ;

Amadori, Sergio ;

Mandelli, Franco .

BLOOD, 2011, 117 (18) :4716-4725

[9] ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF TREATMENT BY DAUNORUBICIN [J].

BERNARD, J ;

WEIL, M ;

BOIRON, M ;

JACQUILLAT, C ;

FLANDRIN, G ;

GEMON, MF .

BLOOD, 1973, 41 (04) :489-496

[10] Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features [J].

Breccia, M. ;

Avvisati, G. ;

Latagliata, R. ;

Carmosino, I. ;

Guarini, A. ;

De Propris, M. S. ;

Gentilini, F. ;

Petti, M. C. ;

Cimino, G. ;

Mandelli, F. ;

Lo-Coco, F. .

LEUKEMIA, 2007, 21 (01) :79-83

← 1 2 3 4 5 6 7 8 9 →